Montréal–Trudeau International Airport to offer rapid screening tests

8 December 2020 (Last Updated December 8th, 2020 12:12)

Aéroports de Montréal (ADM) and Biron Health Group have announced the launch of a pilot project to test a new rapid Covid-19 screening process on departing passengers from Montréal–Trudeau International Airport (YUL) in Quebec, Canada.

Montréal–Trudeau International Airport to offer rapid screening tests
The project will commence on 15 December and will last for an initial period of eight weeks. Credit: Tony Webster from Portland, Oregon on Wikipedia.

Aéroports de Montréal (ADM) and Biron Health Group have announced the launch of a pilot project to test a new rapid Covid-19 screening process on departing passengers from Montréal–Trudeau International Airport (YUL) in Quebec, Canada.

The antigenic tests will make it possible to carry out certified and rapid tests within 15 minutes.

Initially, this new service will be offered by reservation to passengers who are travelling to France.

The service will also be available to those travelling via Air Canada, the initial partner of the project, Air France, and KLM Royal Dutch Airlines or Air Transat.

This project will commence on 15 December and will last for an initial period of eight weeks.

The antigenic test used by Biron is approved by Health Canada and recognised in France.

It uses a nasal swab and will be minimally intrusive. The test will be offered at $149.

The airport noted that other destinations could be added to the pilot project.

Biron professionals will be responsible for the screening in a designated area on the departures level of the airport terminal.

ADM Aéroports de Montréal President and CEO said: “The measures deployed as part of the Travel with Confidence programme at YUL such as taking temperatures and setting up health checkpoints at the three entrances to our terminal, have already proven to be effective. However, it is essential that further initiatives are put forward by airports, airlines and public health teams to ensure that travel is resumed.

“The pilot screening test project improves the procedures already in place and represents a decisive step in ensuring the safest possible travel for passengers. The industry must be innovative and adapt to a new reality, and ADM is proud to be contributing to this effort together with its partners.”

Biron Health Group president and CEO Geneviève Biron said: “The pandemic has had unprecedented impacts on our lives, the Québec economy, and even the entire world. While it is essential to maintain and focus on the public health efforts made to control the pandemic, it is also important to pay attention to the recovery of our economy at the same time.

“We are proud to be collaborating in this pilot project and to support our partners in the revival of airport activities and air transport by leveraging our laboratory expertise and the medical and scientific know-how of our professionals.”